Levi & Korsinsky Investigates Potential Securities Law Violations at Owens & Minor, Inc.
New York, NY – Levi & Korsinsky, a leading securities law firm, is investigating potential securities laws violations at Owens & Minor, Inc. (NYSE: OMI). The investigation follows the company’s press release on February 3, 2025, where Owens & Minor announced selected preliminary financial results for the fourth quarter and year ended December 31, 2024, in advance of its upcoming earnings announcement and conference call.
Background
Owens & Minor, a global healthcare solutions company, provides distributive services and innovative solutions to healthcare providers and manufacturers. The company’s press release stated that it expected to report revenue growth of approximately 11% for the fourth quarter and full-year 2024, compared to the same periods in 2023. Additionally, the company announced that it had made significant progress in its strategic initiatives and was on track to achieve its long-term growth targets.
Investigation Details
Levi & Korsinsky’s investigation focuses on whether Owens & Minor and certain of its officers or directors made false and/or misleading statements regarding the company’s business, financial condition, and prospects. The firm encourages investors who purchased OMI securities between October 1, 2024, and February 2, 2025, to contact the firm.
Impact on Investors
If the investigation uncovers any wrongdoing, Owens & Minor investors could be entitled to significant compensation. It is essential for investors to protect their investments and seek legal advice. If you are an investor in OMI and believe that the company and its executives may have violated federal securities laws, please contact Levi & Korsinsky as soon as possible.
Impact on the World
The investigation could have far-reaching implications for the healthcare industry and the business community as a whole. If it is determined that Owens & Minor and its executives violated securities laws, it could lead to increased scrutiny of other companies in the sector and heightened awareness of the importance of accurate and transparent financial reporting. Furthermore, it could result in stricter regulations and penalties for companies that engage in such practices.
Conclusion
Levi & Korsinsky’s investigation into Owens & Minor is an essential development for investors and the business community. The potential securities law violations could have significant consequences for the company and its executives, as well as the broader healthcare industry. Investors who purchased OMI securities between October 1, 2024, and February 2, 2025, are encouraged to contact Levi & Korsinsky for a confidential consultation. As the investigation progresses, we will continue to provide updates on any new developments.
- Levi & Korsinsky is investigating potential securities law violations at Owens & Minor, Inc.
- The investigation follows the company’s announcement of preliminary financial results.
- The firm encourages investors who purchased OMI securities to contact them.
- If wrongdoing is uncovered, investors could be entitled to compensation.
- The investigation could have implications for the healthcare industry and business community.
